ME Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-03-21 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,290,863 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2024-03-21 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,252,315 | S-Sale | D | 38,548 | 0.46 | 17,894.00 |
2024-03-21 | HIBBS KATHY L | officer: Chief Administrative Officer | 115,647 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2024-03-07 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,290,863 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2024-03-07 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,252,315 | S-Sale | D | 38,548 | 0.53 | 20,430.00 |
2024-03-07 | HIBBS KATHY L | officer: Chief Administrative Officer | 154,195 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2024-02-22 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,278,375 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2024-02-22 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,239,827 | S-Sale | D | 38,548 | 0.61 | 23,325.00 |
2024-02-22 | HIBBS KATHY L | officer: Chief Administrative Officer | 192,743 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2024-02-20 | Richards William G | officer: Head of Therapeutics Discovery | 646,540 | F-InKind | D | 18,497 | 0.72 | 13,244.00 |
2024-02-20 | Selsavage Joseph Anthony | officer: Interim CFO | 1,273,659 | F-InKind | D | 42,395 | 0.72 | 30,355.00 |
2024-02-20 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,239,827 | F-InKind | D | 40,522 | 0.72 | 29,014.00 |
2024-02-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,318,897 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2024-02-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | S-Sale | D | 38,548 | 0.78 | 30,210.00 |
2024-02-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 231,291 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2024-01-25 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,318,897 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2024-01-25 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | S-Sale | D | 38,548 | 0.73 | 27,997.00 |
2024-01-25 | HIBBS KATHY L | officer: Chief Administrative Officer | 269,839 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2024-01-11 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,318,897 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2024-01-11 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | S-Sale | D | 38,548 | 0.72 | 27,581.00 |
2024-01-11 | HIBBS KATHY L | officer: Chief Administrative Officer | 308,387 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-12-28 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,318,897 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-12-28 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | S-Sale | D | 38,548 | 0.93 | 35,904.00 |
2023-12-28 | HIBBS KATHY L | officer: Chief Administrative Officer | 346,935 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-12-14 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,318,897 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-12-14 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | S-Sale | D | 38,548 | 0.97 | 37,222.00 |
2023-12-14 | HIBBS KATHY L | officer: Chief Administrative Officer | 385,483 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-11-30 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,318,897 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-11-30 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | S-Sale | D | 38,548 | 0.88 | 33,753.00 |
2023-11-30 | HIBBS KATHY L | officer: Chief Administrative Officer | 424,031 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-11-20 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,280,349 | F-InKind | D | 4,627 | 0.91 | 4,211.00 |
2023-11-20 | Richards William G | officer: Head of Therapeutics Discovery | 665,037 | F-InKind | D | 5,695 | 0.91 | 5,182.00 |
2023-11-20 | Selsavage Joseph Anthony | officer: Interim CFO | 1,316,054 | F-InKind | D | 6,208 | 0.91 | 5,649.00 |
2023-11-16 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,323,524 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-11-16 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,284,976 | S-Sale | D | 38,548 | 0.77 | 29,732.00 |
2023-11-16 | HIBBS KATHY L | officer: Chief Administrative Officer | 462,579 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-11-02 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,323,524 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-11-02 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,284,976 | S-Sale | D | 38,548 | 0.87 | 33,437.00 |
2023-11-02 | HIBBS KATHY L | officer: Chief Administrative Officer | 501,127 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-10-19 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,323,524 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-10-19 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,284,976 | S-Sale | D | 38,548 | 0.81 | 31,397.00 |
2023-10-19 | HIBBS KATHY L | officer: Chief Administrative Officer | 598,475 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-10-05 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,323,524 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-10-05 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,284,976 | S-Sale | D | 38,548 | 0.84 | 32,407.00 |
2023-10-05 | HIBBS KATHY L | officer: Chief Administrative Officer | 637,023 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-09-21 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,323,524 | M-Exempt | A | 38,548 | 0.42 | 16,190.00 |
2023-09-21 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,284,976 | S-Sale | D | 38,548 | 1.00 | 38,583.00 |
2023-09-21 | HIBBS KATHY L | officer: Chief Administrative Officer | 675,571 | M-Exempt | D | 38,548 | 0.42 | 16,190.00 |
2023-09-15 | Wojcicki Anne | director, 10 percent owner, officer: Chief Executive Officer | 9,527,115 | A-Award | A | 9,527,115 | 1.10 | 10,479,826.00 |
2023-09-15 | Selsavage Joseph Anthony | officer: Interim CFO | 1,322,262 | A-Award | A | 1,025,992 | 0.00 | 0.00 |
2023-09-15 | Selsavage Joseph Anthony | officer: Interim CFO | 496,204 | A-Award | A | 496,204 | 1.10 | 545,824.00 |
2023-09-15 | Richards William G | officer: Head of Therapeutics Discovery | 670,732 | A-Award | A | 115,641 | 0.00 | 0.00 |
2023-09-15 | Richards William G | officer: Head of Therapeutics Discovery | 555,091 | A-Award | A | 344,050 | 0.00 | 0.00 |
2023-09-15 | Richards William G | officer: Head of Therapeutics Discovery | 166,394 | A-Award | A | 166,394 | 1.10 | 183,033.00 |
2023-09-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 1,284,976 | A-Award | A | 1,025,992 | 0.00 | 0.00 |
2023-09-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 496,204 | A-Award | A | 496,204 | 1.10 | 545,824.00 |
2023-09-07 | HIBBS KATHY L | officer: Chief Administrative Officer | 714,119 | M-Exempt | D | 40,896 | 0.42 | 17,176.00 |
2023-09-07 | HIBBS KATHY L | officer: Chief Administrative Officer | 299,880 | M-Exempt | A | 40,894 | 0.42 | 17,175.00 |
2023-09-07 | HIBBS KATHY L | officer: Chief Administrative Officer | 258,984 | S-Sale | D | 40,894 | 1.06 | 43,483.00 |
2023-09-06 | Hernandez Sandra R MD | director | 337,549 | A-Award | A | 45,871 | 1.09 | 49,999.00 |
2023-09-06 | Hernandez Sandra R MD | director | 291,678 | A-Award | A | 148,492 | 0.00 | 0.00 |
2023-09-06 | SCHELLER RICHARD H | director | 237,476 | A-Award | A | 165,088 | 0.00 | 0.00 |
2023-09-06 | MONTGOMERY RICE VALERIE MD | director | 339,544 | A-Award | A | 59,633 | 1.09 | 65,000.00 |
2023-09-06 | MONTGOMERY RICE VALERIE MD | director | 279,911 | A-Award | A | 130,862 | 0.00 | 0.00 |
2023-09-06 | Mohan Neal | director | 245,806 | A-Award | A | 154,997 | 0.00 | 0.00 |
2023-09-06 | Chung Patrick S | director | 301,421 | A-Award | A | 61,926 | 1.09 | 67,499.00 |
2023-09-06 | Chung Patrick S | director | 239,495 | A-Award | A | 126,461 | 0.00 | 0.00 |
2023-09-06 | BOTHA ROELOF | director, 10 percent owner: | 193,379 | A-Award | A | 55,045 | 1.09 | 59,999.00 |
2023-09-06 | BOTHA ROELOF | director, 10 percent owner: | 138,334 | A-Award | A | 138,334 | 0.00 | 0.00 |
2023-09-06 | Taylor Peter J. | director | 265,217 | A-Award | A | 137,566 | 0.00 | 0.00 |
2023-09-05 | Richards William G | officer: Head of Therapeutics Discovery | 211,041 | S-Sale | D | 2,538 | 1.08 | 2,741.00 |
2023-08-24 | HIBBS KATHY L | officer: Chief Administrative Officer | 755,015 | M-Exempt | D | 40,894 | 0.42 | 17,175.00 |
2023-08-24 | HIBBS KATHY L | officer: Chief Administrative Officer | 293,406 | M-Exempt | A | 40,894 | 0.42 | 17,175.00 |
2023-08-24 | HIBBS KATHY L | officer: Chief Administrative Officer | 252,512 | S-Sale | D | 40,894 | 1.05 | 43,119.00 |
2023-08-20 | HIBBS KATHY L | officer: Chief Administrative Officer | 252,512 | F-InKind | D | 4,628 | 1.14 | 5,276.00 |
2023-08-20 | Selsavage Joseph Anthony | officer: Interim CFO | 286,537 | F-InKind | D | 6,209 | 1.14 | 7,078.00 |
2023-08-20 | Richards William G | officer: Head of Therapeutics Discovery | 211,041 | F-InKind | D | 8,185 | 1.14 | 9,331.00 |
2023-08-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 795,909 | M-Exempt | D | 40,894 | 0.42 | 17,175.00 |
2023-08-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 298,034 | M-Exempt | A | 40,894 | 0.42 | 17,175.00 |
2023-08-15 | HIBBS KATHY L | officer: Chief Administrative Officer | 257,140 | S-Sale | D | 40,894 | 1.32 | 53,939.00 |
2023-08-08 | Richards William G | officer: Head of Therapeutics Discovery | 219,226 | D | 0 | 0.00 | 0.00 | |
2023-08-08 | Richards William G | officer: Head of Therapeutics Discovery | 0 | D | 55,048 | 5.04 | 277,442.00 | |
2023-08-08 | Richards William G | officer: Head of Therapeutics Discovery | 0 | D | 30,000 | 8.20 | 246,000.00 | |
2023-08-08 | Richards William G | officer: Head of Therapeutics Discovery | 0 | D | 38,783 | 12.62 | 489,441.00 | |
2023-08-08 | Richards William G | officer: Head of Therapeutics Discovery | 0 | D | 80,545 | 3.56 | 286,740.00 | |
2023-08-08 | Richards William G | officer: Head of Therapeutics Discovery | 0 | D | 50,640 | 2.20 | 111,408.00 | |
2023-07-27 | HIBBS KATHY L | officer: Chief Administrative Officer | 836,803 | M-Exempt | D | 40,894 | 0.42 | 17,175.00 |
2023-07-27 | HIBBS KATHY L | officer: Chief Administrative Officer | 298,034 | M-Exempt | A | 40,894 | 0.42 | 17,175.00 |
2023-07-27 | HIBBS KATHY L | officer: Chief Administrative Officer | 257,140 | S-Sale | D | 40,894 | 1.89 | 77,257.00 |
2023-07-13 | HIBBS KATHY L | officer: Chief Administrative Officer | 877,697 | M-Exempt | D | 40,894 | 0.42 | 17,175.00 |
2023-07-13 | HIBBS KATHY L | officer: Chief Administrative Officer | 298,034 | M-Exempt | A | 40,894 | 0.42 | 17,175.00 |
2023-07-13 | HIBBS KATHY L | officer: Chief Administrative Officer | 257,140 | S-Sale | D | 40,894 | 1.82 | 74,239.00 |
2023-06-29 | HIBBS KATHY L | officer: Chief Administrative Officer | 918,591 | M-Exempt | D | 40,894 | 0.42 | 17,175.00 |
2023-06-29 | HIBBS KATHY L | officer: Chief Administrative Officer | 298,034 | M-Exempt | A | 40,894 | 0.42 | 17,175.00 |
2023-06-29 | HIBBS KATHY L | officer: Chief Administrative Officer | 257,140 | S-Sale | D | 40,894 | 1.72 | 70,432.00 |
2023-06-05 | HIBBS KATHY L | officer: Chief Administrative Officer | 272,238 | A-Award | A | 43,659 | 0.00 | 0.00 |
2023-06-05 | HIBBS KATHY L | officer: Chief Administrative Officer | 257,140 | F-InKind | D | 15,098 | 2.08 | 31,404.00 |
2023-06-05 | Hillan Kenneth J. | officer: Chief Therapeutics Officer | 237,223 | A-Award | A | 44,381 | 0.00 | 0.00 |
2023-06-05 | Hillan Kenneth J. | officer: Chief Therapeutics Officer | 221,876 | F-InKind | D | 15,347 | 2.08 | 31,922.00 |
2023-06-05 | Selsavage Joseph Anthony | officer: Interim CFO | 305,821 | A-Award | A | 37,808 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.